1513 related articles for article (PubMed ID: 8326181)
21. Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy.
Chiplunkar SV; Deshmukh MV; Samson PD; Butlin R; Bhatki WS; Chulawalla RG; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):334-41. PubMed ID: 2376683
[TBL] [Abstract][Full Text] [Related]
22. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
23. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
24. Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients.
Ohman R; Walford C; Converse P; Ridell M
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):320-2. PubMed ID: 2071990
[No Abstract] [Full Text] [Related]
25. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
Mathew JM; Muthukkaruppan V
Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
[TBL] [Abstract][Full Text] [Related]
26. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
Mohanty KK; Joshi B; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
[TBL] [Abstract][Full Text] [Related]
28. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
29. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
30. Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.
Macfarlane A; Mondragon-Gonzalez R; Vega-Lopez F; Wieles B; de Pena J; Rodriguez O; Suarez y de la Torre R; de Vries RR; Ottenhoff TH; Dockrell HM
Clin Diagn Lab Immunol; 2001 May; 8(3):604-11. PubMed ID: 11329466
[TBL] [Abstract][Full Text] [Related]
31. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
32. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
33. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
34. [Correlation of skin tests and the production of gamma-interferon in leprosy patients].
Suso L; Nogueira N; Vieira LM; Figueiredo AA; Porto JA; Sarno EN
Med Cutan Ibero Lat Am; 1988; 16(3):193-6. PubMed ID: 3143869
[TBL] [Abstract][Full Text] [Related]
35. Preliminary study of cellular immunity to Mycobacterium leprae protein in contacts and leprosy patients.
Rada EM; Santaella C; Aranzazu N; Convit J
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):189-94. PubMed ID: 1522361
[TBL] [Abstract][Full Text] [Related]
36. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
Bach MA; Wallach D; Flageul B; Cottenot F
Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
[TBL] [Abstract][Full Text] [Related]
37. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590
[TBL] [Abstract][Full Text] [Related]
38. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
[TBL] [Abstract][Full Text] [Related]
39. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
40. A method for the detection of M. leprae antigens in urine of leprosy patients by gel diffusion and gel electrophoretic techniques and significance in diagnosis.
Patil SA; Katoch K; Sengupta U
Acta Leprol; 1991; 7(5):403-7. PubMed ID: 1805496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]